CORD-19:3c1f47a07aaf0e393dee9fbd08596a4b9f4f0a03 / 83769-83947 JSONTXT

Annnotations TAB JSON ListView MergeView

    CORD-19-Sentences

    {"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T675","span":{"begin":0,"end":178},"obj":"Sentence"},{"id":"T29212","span":{"begin":0,"end":178},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Objectives of study: MSP-2 is a highly polymorphic 45−53 kDa merozoite surface antigen and very immunogenic malaria antigen, which is considered as a promising vaccine candidate."}

    CORD-19_Custom_license_subset

    {"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T233","span":{"begin":0,"end":178},"obj":"Sentence"}],"text":"Objectives of study: MSP-2 is a highly polymorphic 45−53 kDa merozoite surface antigen and very immunogenic malaria antigen, which is considered as a promising vaccine candidate."}

    Epistemic_Statements

    {"project":"Epistemic_Statements","denotations":[{"id":"T169","span":{"begin":0,"end":178},"obj":"Epistemic_statement"}],"text":"Objectives of study: MSP-2 is a highly polymorphic 45−53 kDa merozoite surface antigen and very immunogenic malaria antigen, which is considered as a promising vaccine candidate."}

    CORD-19-PD-MONDO

    {"project":"CORD-19-PD-MONDO","denotations":[{"id":"T293","span":{"begin":108,"end":115},"obj":"Disease"},{"id":"T91110","span":{"begin":108,"end":115},"obj":"Disease"}],"attributes":[{"id":"A293","pred":"mondo_id","subj":"T293","obj":"http://purl.obolibrary.org/obo/MONDO_0005136"},{"id":"A82949","pred":"mondo_id","subj":"T91110","obj":"http://purl.obolibrary.org/obo/MONDO_0005136"}],"text":"Objectives of study: MSP-2 is a highly polymorphic 45−53 kDa merozoite surface antigen and very immunogenic malaria antigen, which is considered as a promising vaccine candidate."}